Who May Not Be a Good Candidate
Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new orforglipron pill can offer up to an average of 27.3 pounds of weight loss, according to results from the first of two of its Phase 3 trials that included more than 3,100 overweight or obese adults
Some surgeons recommend adjusting or temporarily pausing GLP-1 medications around the time of surgery due to concerns such as delayed gastric emptying and anesthesia safety
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
Nat Rev Endocrinol 13(10):610622 Kujur A, Srivastava N, Kumar B, Jasrotia N, Arunpandian J, Ganeshan M (2021) Fetal congenital goiter in goat: a case report
A full 15 mg dose requires only 25 units